EP3062811
Inngrip með Angiopoietin meðferð við heilamalaríu
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
31.10.2014EP published:
3.4.2019EP application number:
14800207.4
EP translation filed:
29.4.2019Grant published:
15.6.2019EPO information:
European Patent Register
Max expiry date:
30.10.2034Expiry date:
30.10.2021
Title:
ANGIOPOIETIN-BASED INTERVENTIONS FOR TREATING CEREBRAL MALARIA
Timeline
Today
31.10.2014EP application
3.4.2019EP Publication
29.4.2019Translation submitted
15.6.2019Registration published
30.10.2021Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, 10591, Tarrytown, NY, US
Name:
University Health Network (UHN)Address:
190 Elizabeth Street R. Fraser Elliott Building Room 1S-417, Toronto, Ontario M5G 2C4, CA
Inventor
Name:
PURCELL NGAMBO, Lisa ArleenAddress:
Garnerville, NY, US
Name:
HIGGINS, Sarah, J.Address:
Toronto, ON M5G 1L7, CA
Name:
KAIN, Kevin, C.Address:
Toronto, ON M4R 1K5, CA
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201361898539 PDate:
1.11.2013Country:
US
Number:
201462040514 PDate:
22.8.2014Country:
US
Classification
Categories:
A61K 38/16, A61K 38/17, A61K 38/18, A61K 39/395, A61P 33/06
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 18.9.2019
Expires: 30.10.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 7
Paid: 17.9.2020
Expires: 30.10.2021
Payer: Patice ehf.